Evidence map›Paper›PMID 32109011›Full record

ArticleThe New England journal of medicine2020

Covid-19 - Navigating the Uncharted.

Anthony S Fauci, H Clifford Lane, Robert R Redfield

8 registry-linked trialsAbstract readEditorialComment
In one paragraph

Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 850 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
850citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04336215 completednot on this map

Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers

TypeobservationalSponsorRutgers, The State University of New JerseyRan2020 to 2024Enrolled829ConditionsCoronavirus, SARS-CoV-2ArmsNon-Interventional
NCT04348240 completednot on this map

Transmissibility and Viral Load of SARS-CoV-2 Through Oral Secretions

TypeobservationalSponsorNational Institute of Dental and Craniofacial Research (NIDCR)Ran2020 to 2022Enrolled55ConditionsCOVID-19
NCT04362176 phase3completednot on this map

Passive Immunity Trial for Our Nation (PassItOn)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2020 to 2021Enrolled974ConditionsCOVID-19, Coronavirus, SARS-CoV-2Armspathogen reduced SARS-CoV-2 convalescent plasma, Placebo
NCT04372628 phase2completednot on this map

Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19

TypeinterventionalSponsorVanderbilt University Medical CenterRan2020 to 2022Enrolled452ConditionsCOVID-19ArmsLopinavir/Ritonavir 400 mg/100 mg, Placebo
NCT04729140 phase4unknown statusnot on this map

A Randomized Double-blinded Placebo-controlled Outpatient Clinical Trial in High Risk Population Confirmed COVID-19 Patients Using Ivermectin and Doxycycline to Prevent COVID-19 Illness-related Hospitalization (COVIVER-OUT PLUS)

TypeinterventionalSponsorMax Health, Subsero HealthRan2020 to 2022Enrolled150ConditionsCovid19ArmsIvermectin Tablets, Doxycycline Tablets, Placebo
NCT04777981 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Efficacy of Cannabidiol in Combination With Red Algae (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection PASC

TypeinterventionalSponsorAnewsha Therapeutics Inc.Ran2022 to 2022Enrolled60ConditionsCOVID-19, SARArmsCBDRA60 supplement, Placebo
NCT04982263 completednot on this mapstarted 2021, after this paper: background citation

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

TypeobservationalSponsorSohag UniversityRan2021 to 2021Enrolled125ConditionsCovid19ArmsBlood coagulation profile
NCT05392088 unknown statusnot on this mapstarted 2022, after this paper: background citation

Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.

Typeobservational_patient_registrySponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2022 to 2024Enrolled1,500ConditionsMyocardial Injury, COVID-19ArmsDATA EXTRACTION, FOLLOW-UP
3 · Its place in the literature

Who cites it

850 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

790 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Anthony S FauciFrom the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (A.S.F., H.C.L.); and the Centers for Disease Control and Prevention, Atlanta (R.R.R.).
H Clifford LaneFrom the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (A.S.F., H.C.L.); and the Centers for Disease Control and Prevention, Atlanta (R.R.R.).ORCID 0000-0001-9509-1045
Robert R RedfieldFrom the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (A.S.F., H.C.L.); and the Centers for Disease Control and Prevention, Atlanta (R.R.R.).

Funding

Pathogenesis, Treatment and Prevention of Emerging Infectious DiseasesZIAAI000936 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LANE, CLIFFORD · 2009 to 2025
$6.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCoronavirus InfectionsGlobal HealthPandemicsPneumonia, ViralAge FactorsAsymptomatic DiseasesBasic Reproduction NumberBetacoronavirusChinaCOVID-19COVID-19 Drug TreatmentCOVID-19 VaccinesDisease ProgressionFemaleHospitalizationCOVID-19 VaccinesViral Vaccines

Identifiers

PMID32109011
PMCPMC7121221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.